MY138934A - Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride - Google Patents
Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochlorideInfo
- Publication number
- MY138934A MY138934A MYPI20032577A MY138934A MY 138934 A MY138934 A MY 138934A MY PI20032577 A MYPI20032577 A MY PI20032577A MY 138934 A MY138934 A MY 138934A
- Authority
- MY
- Malaysia
- Prior art keywords
- indol
- piperidin
- ylmethyl
- dione
- pyridin
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
THE PRESENT INVENTION RELATES TO CRYSTALLINE 2,5-DIONE-3-(1-METHYL-1H-INDOL-3-YL)-4-[ 1-(PYRIDIN-2-YLMETHYL)PIPERIDIN-4-YL]-1H-INDOL-3-YL]-1H-PYRROLE MONO-HYDROCHLORIDE SALT, A PHARMACEUTICAL FORMULATION CONTAINING SAID SALT AND TO METHODS FOR TREATING CANCER AND FOR INHIBITING TUMOR GROWTH USING SAID SALT.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20032577 MY138934A (en) | 2002-07-23 | 2003-07-09 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MYPI20022777 MY139957A (en) | 2002-07-23 | 2002-07-23 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride |
MYPI20032577 MY138934A (en) | 2002-07-23 | 2003-07-09 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
MY138934A true MY138934A (en) | 2009-08-28 |
Family
ID=45699544
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20022777 MY139957A (en) | 2002-07-23 | 2002-07-23 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride |
MYPI20032577 MY138934A (en) | 2002-07-23 | 2003-07-09 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI20022777 MY139957A (en) | 2002-07-23 | 2002-07-23 | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-1-(pyridin-2-ylmethyl)piperidin-4-yl-1h-indol-3-yl-1h-pyrrole mono-hydrochloride |
Country Status (1)
Country | Link |
---|---|
MY (2) | MY139957A (en) |
-
2002
- 2002-07-23 MY MYPI20022777 patent/MY139957A/en unknown
-
2003
- 2003-07-09 MY MYPI20032577 patent/MY138934A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MY139957A (en) | 2009-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20050035B1 (en) | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride | |
IL171976A0 (en) | Indazole, benzisoxazole, and banzisothiazole kinase inhibitors | |
AP9901478A0 (en) | Compounds for the treatment of ischemia. | |
UA84712C2 (en) | N-substituted pyrazolyl-amidyl-benzimidazolyl c-kit inhibitors | |
YU61402A (en) | Pyrrole substituted 2-indolinone protein kinase inhibitors | |
PL406680A1 (en) | Tyrosine kinase inhibitors | |
WO2003051366A3 (en) | 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer | |
TW200621715A (en) | Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors | |
TR200200205T2 (en) | Treating chronic pain using MEK inhibitors | |
TNSN05045A1 (en) | Indole or benzimidazole derivatives for modulating ikappab kinase | |
ATE381557T1 (en) | RHO KINASE INHIBITORS | |
MY143599A (en) | Pyrazole derivatives, compositions containing such compounds and methods of use | |
EP1617840A4 (en) | Pyrazole-amide compounds useful as kinase inhibitors | |
RS20050116A (en) | Novel phenanthridines | |
RS60404A (en) | Controlled synthesis of ziprasidone and compositions thereof | |
IL162203A0 (en) | Indolinone derivatives useful as protein inase inhibitors | |
HK1085675A1 (en) | Anticancer compounds | |
MXPA05009611A (en) | SUBSTITUTED PIPERIDINES AS NOVEL MDM2-p53 INHIBITORS. | |
WO1992020336A3 (en) | Novel cholesterol lowering compounds | |
WO2003106450A8 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
MXPA02000330A (en) | Neurotrophic pyrrolidines and piperidines, and related compositions and methods. | |
WO2004058705A3 (en) | Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor | |
MXPA03004879A (en) | Farnesyltransferase inhibitors. | |
MY138934A (en) | Crystalline 2,5-dione-3-(1-methyl-1h-indol-3-yl)-4-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1h-indol-3-yl]-1h-pyrrole mono-hydrochloride | |
TW200503722A (en) | Substituted 7-aza-quinazoline compounds |